XRXiang Ren

Xiang Ren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiang Ren has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Li Kong

    Department of Histology and Embryology, College of Basic Medicine, Dalian Medical University, Dalian 116044, China

    9 shared publications
  • Maryam Chudhary

    Department of Histology and Embryology, Dalian Medical University

    5 shared publications
  • Shiyu Song

    Department of Histology and Embryology, College of Basic Medicine, Dalian Medical University, Dalian, Liaoning 116044, P.R. China

    4 shared publications
  • Limin Wei

    Department of Histology and Embryology, College of Basic Medicine, Dalian Medical University

    3 shared publications
  • Wenkang Dong

    Department of Histology and Embryology, Dalian Medical University

    3 shared publications
  • Wenkang Dong

    Department of Histology and Embryology, College of Basic Medicine, Dalian Medical University, Dalian 116044, China

    3 shared publications

Latest Publications

  • Ginkgo Biloba Standardized Extract EGb 761 Reduces Light and Toxin-Induced Photoreceptor Cell Damage via Regulating Oxidative Stress and Autophagy

    by Qiufeng Teng, Maryam Chudhary, Wenkang Dong, Yang Yu, Yulang Meng, Jinjuan Lv, Siyang Liu, Bing Wang, Xiang Ren

    Retinal degeneration (RD) refers to a group of vision-threatening disorders and leads to gradual vision loss or permanent vision impairment. It mainly includes age-related macular degeneration and ...

  • Open Access

    Upregulation of Trx alleviated high-glucose-induced Müller cell pyroptosis through ASK-1/Cav-1-mediated endoplasmic reticulum stress and autophagy

    by Kaimin Bao, Xuebin Yu, Limin Wei, Yang Yu, Shiwen Zhong, Zhiyi Ren, Hongyang Chen, Li Kong, Xiang Ren, Hui Kong

    Objectives: Diabetic retinopathy (DR) is a vision-threatening complication of diabetes. A high-glucose state induces endoplasmic reticulum stress (ERS) and autophagy in retinal Müller cells and further triggers pyroptosis, which ultimately promotes the progression of DR. Apoptosis signal-regulating kinase 1 (ASK1) and caveolin-1 (Cav-1) have been found to be closely associated with ERS and autophagy. Thioredoxin (Trx), a small-molecule protein, is essential for regulating cellular function. However, the regulatory mechanisms linking these molecules are not fully understood in DR. In this study, we investigated the role and mechanism of Trx in alleviating high-glucose-induced pyroptosis in Müller cells. Study design: Serum samples from patients with diabetes, diabetic mice, and Müller cells were used in the study. Results: In vivo and in vitro , high glucose can lead to increased expression of retinal inflammatory factors, morphological damage, and induction of cell pyroptosis. After high-glucose treatment, the expression of ERS- and pyroptosis-related genes increased. This process was reversed after Trx overexpression. Furthermore, autophagy was activated, and the number of TUNEL-positive cells decreased. These effects were reversed by Cav-1 inhibitor treatment. Conclusions: Trx overexpression could delay high-glucose-induced Müller cell pyroptosis by regulating ERS and autophagy via ASK-1/Cav-1, providing a new therapeutic target for DR treatment.


  • Open Access

    Txnip/Trx Is a Potential Element in Regulating O-GlcNAc Modification in Photoreceptors to Alleviate Diabetic Retinopathy

    by Laraib Imdad, Shengnan Xu, Yulang Meng, Kaimin Bao, Wenkang Dong, Xuanya Yin, Yujie Tong, Wei Zhang, Xiang Ren, Li Kong

    Hyperglycemia is a key factor in diabetic retinopathy which leads to blindness. O-linked-N-acetylglucosamine (O-GlcNAc) modification changes are linked to various diseases, including diabetic retinopathy. This research aims to study the roles of Txnip and Trx in influencing O-GlcNAc in photoreceptor cells during diabetic retinopathy. A diabetic mouse model and 661w cells, after exposure to high glucose, were employed as models. H&E staining and ERG were used to evaluate the morphology and function of the retina, respectively. Western blotting was used to analyze protein expression, a TUNEL assay was used to measure apoptosis, and a co-immunoprecipitation (CO-IP) assay was used to detect the interactions of protein. In diabetic mice, electroretinogram (ERG) amplitude wave, retinal thickness, and body weight decreased. Glial fibrillary acidic protein (GFAP), Iba1 expression, and blood glucose level increased. In vitro, the percentage of apoptotic cell, Bax, and caspase3 levels increased, and Bcl2 decreased in 661w cells under high-glucose conditions. Moreover, Txnip expression was upregulated, while Trx was downregulated. Additionally, a Western blot analysis revealed that high-glucose exposure led to increased O-GlcNAc modification both in vivo and in vitro. The CO-IP results show that Txnip interacted with O-GlcNAc modifications. S-opsin expression was significantly downregulated in vitro under high-glucose conditions. Knockdown Txnip or upregulation Trx could reverse or delay apoptosis in 661w cells under hyperglycemic conditions. Txnip/Trx is a potential element in regulating photoreceptor apoptosis in diabetic retinopathy. The underlying mechanism is linked to regulation of O-GlcNAc modification in photoreceptor cells in DR.


  • Open Access

    Oxidative and endoplasmic reticulum stress in diabetes-related hearing loss: Protective effects of thioredoxin

    by Meng Xu, Shiwen Zhong, Na Zhu, Sifan Wang, Jingyi Wang, Xiang Li, Xiang Ren, Hui Kong


  • Open Access

    O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy

    by Wenkang Dong, Laraib Imdad, Shengnan Xu, Yinli Wang, Chengzhi Liu, Shiyu Song, Zechuan Li, Ying Kong, Li Kong, Xiang Ren

    Diabetic retinopathy (DR) is a very serious diabetes complication. Changes in the O-linked N-acetylglucosamine (O-GlcNAc) modification are associated with many diseases. However, its role in DR is not fully understood. In this research, we explored the effect of O-GlcNAc modification regulation by activating AMP-activated protein kinase (AMPK) in DR, providing some evidence for clinical DR treatment in the future. Bioinformatics was used to make predictions from the database, which were validated using the serum samples of diabetic patients. As an in vivo model, diabetic mice were induced using streptozotocin (STZ) injection with/without an AMPK agonist (metformin) or an AMPK inhibitor (compound C) treatment. Electroretinogram (ERG) and H&E staining were used to evaluate the retinal functional and morphological changes. In vitro, 661 w cells were exposed to high-glucose conditions, with or without metformin treatment. Apoptosis was evaluated using TUNEL staining. The protein expression was detected using Western blot and immunofluorescence staining. The angiogenesis ability was detected using a tube formation assay. The levels of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) in the serum changed in the DR patients in the clinic. In the diabetic mice, the ERG wave amplitude and retinal thickness decreased. In vitro, the apoptotic cell percentage and Bax expression were increased, and Bcl2 expression was decreased in the 661 w cells under high-glucose conditions. The O-GlcNAc modification was increased in DR. In addition, the expression of GFAT/TXNIP O-GlcNAc was also increased in the 661 w cells after the high-glucose treatment. Additionally, the Co-immunoprecipitation(CO-IP) results show that TXNIP interacted with the O-GlcNAc modification. However, AMPK activation ameliorated this effect. We also found that silencing the AMPKα1 subunit reversed this process. In addition, the conditioned medium of the 661 w cells may have affected the tube formation in vitro. Taken together, O-GlcNAc modification was increased in DR with photoreceptor cell degeneration and neovascularization; however, it was reversed after activating AMPK. The underlying mechanism is linked to the GFAT/TXNIP-O-GlcNAc modification signaling axis. Therefore, the AMPKα1 subunit plays a vital role in the process.


  • Open Access

    Mapping the current trends of autophagy in retinal diseases: A bibliometric analysis

    by Chengzhi Liu, Xiaonan Li, Laraib Imdad, Shengnan Xu, Jun Li, Xiang Ren


  • Thioredoxin 1 overexpression attenuated diabetes‐induced endoplasmic reticulum stress in Müller cells via apoptosis signal‐regulating kinase 1

    by Xuebin Yu, Qiufeng Teng, Kaimin Bao, Maryam Chudhary, Hui Qi, Wenying Zhou, Hongxin Che, Junli Liu, Xiang Ren, Li Kong

    As one of the common and serious chronic complications of diabetes mellitus (DM), the related mechanism of diabetic retinopathy (DR) has not been fully understood. Müller cell reactive gliosis is one of the early pathophysiological features of DR. Therefore, exploring the manner to reduce diabetes‐induced Müller cell damage is essential to delay DR. Thioredoxin 1 (Trx1), one of the ubiquitous redox enzymes, plays a vital role in redox homeostasis via protein–protein interactions, including apoptosis signal‐regulating kinase 1 (ASK1). Previous studies have shown that upregulation of Trx by some drugs can attenuate endoplasmic reticulum stress (ERS) in DR, but the related mechanism was unclear. In this study, we used DM mouse and high glucose (HG)‐cultured human Müller cells as models to clarify the effect of Trx1 on ERS and the underlying mechanism. The data showed that the diabetes‐induced Müller cell damage was increased significantly. Moreover, the expression of ERS and reactive gliosis was also upregulated in diabetes in vivo and in vitro. However, it was reversed after Trx1 overexpression. Besides, ERS‐related protein expression, reactive gliosis, and apoptosis were decreased after transfection with ASK1 small‐interfering RNA in stable Trx1 overexpression Müller cells after HG treatment. Taken together, Trx1 could protect Müller cells from diabetes‐induced damage, and the underlying mechanism was related to inhibited ERS via ASK1.


  • Open Access

    Role of Takeda G protein‑coupled receptor 5 in microvascular endothelial cell dysfunction in diabetic retinopathy (Review)

    by Miao Zhang, Zhenghao Dong, Wenkang Dong, Dongdong Zhou, Xiang Ren

    Diabetic retinopathy (DR) is a frequent microvascular complication of advanced‑stage diabetes. Endothelial cell dysfunction (ED) induced by diabetes plays an important role in the development of DR. It is considered that inflammation and mitochondrial homeostasis are associated with the progression of ED. Takeda G protein‑coupled receptor 5 (TGR5) is a membrane receptor for bile acids (BAs) that plays an important role in regulating BA metabolism. Recent studies have shown that TGR5 is involved in regulating various mediators of ED and improving the dysfunction of vascular endothelial cells in DR; however, the exploration of specific related mechanisms remains an active research area in this field, which suggests that TGR5 may be one of the potential targets for the treatment of associated ED in DR. In the present review, the association between TGR5 and mitochondrial homeostasis was investigated. The extent of inflammation in DR‑induced ED was assessed to provide possible evidence for the development of targeted therapies against DR.


  • Open Access

    Thioredoxin-interacting protein in diabetic retinal neurodegeneration: A novel potential therapeutic target for diabetic retinopathy

    by Chengzhi Liu, Wenkang Dong, Zhengshuai Lv, Li Kong, Xiang Ren

    Diabetic retinopathy (DR) is a common complication of diabetes mellitus and has been considered a microvascular disease for a long time. However, recent evidence suggests that diabetic retinal neurodegeneration (DRN), which manifests as neuronal apoptosis, a decrease in optic nerve axons, and reactive gliosis, occurs prior to retinal microvascular alterations. Thioredoxin-interacting protein (TXNIP) is an endogenous inhibitor of thioredoxin (Trx), and it acts by inhibiting its reducing capacity, thereby promoting cellular oxidative stress. In addition, it participates in regulating multiple signaling pathways as a member of the α-arrestin family of proteins. Accumulating evidence suggests that TXNIP is upregulated in diabetes and plays a pivotal role in the pathophysiological process of DR. In this review, we summarized the role of TXNIP in DRN, aiming to provide evidence for DR treatment in the future.


  • Open Access

    O-GlcNAc Modification and Its Role in Diabetic Retinopathy

    by Chengzhi Liu, Wenkang Dong, Jun Li, Ying Kong, Xiang Ren

    Diabetic retinopathy (DR) is a leading complication in type 1 and type 2 diabetes and has emerged as a significant health problem. Currently, there are no effective therapeutic strategies owing to its inconspicuous early lesions and complex pathological mechanisms. Therefore, the mechanism of molecular pathogenesis requires further elucidation to identify potential targets that can aid in the prevention of DR. As a type of protein translational modification, O-linked β-N-acetylglucosamine (O-GlcNAc) modification is involved in many diseases, and increasing evidence suggests that dysregulated O-GlcNAc modification is associated with DR. The present review discusses O-GlcNAc modification and its molecular mechanisms involved in DR. O-GlcNAc modification might represent a novel alternative therapeutic target for DR in the future.